Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M, Ortega-Alonso A, Matilla-Cabello G, Medina-Cáliz I, Castiella A, Conde I, Bonilla-Toyos E, Pinazo-Bandera J, Hernández N, Tagle M, Nunes V, Parana R, Bessone F, Kaplowitz N, Lucena MI, Alvarez-Alvarez I, Robles-Díaz M, Andrade RJ. García-Cortés M, et al. Among authors: bessone f. Liver Int. 2023 Aug;43(8):1749-1760. doi: 10.1111/liv.15623. Epub 2023 Jun 3. Liver Int. 2023. PMID: 37269163
[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
Silva MO, Ridruejo E, Galdame O, Bessone F, Colombato L, Daruich J, Fainboim H, Fassio E, Fay F, Frider B, Gadano A, Galoppo MC, González J, Tanno H, Terg R, Villamil F; Comisión de Expertos en Hepatitis Virales de la Asociaci6n Argentina para el Estudio de las Enfermedades; del Hígado. Silva MO, et al. Among authors: bessone f. Acta Gastroenterol Latinoam. 2012 Sep;42(3):234-49. Acta Gastroenterol Latinoam. 2012. PMID: 23214356 Spanish. No abstract available.
Hepatitis C virus infection in Argentina: Burden of chronic disease.
Ridruejo E, Bessone F, Daruich JR, Estes C, Gadano AC, Razavi H, Villamil FG, Silva MO. Ridruejo E, et al. Among authors: bessone f. World J Hepatol. 2016 May 28;8(15):649-58. doi: 10.4254/wjh.v8.i15.649. World J Hepatol. 2016. PMID: 27239258 Free PMC article.
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
Piratvisuth T, Komolmit P, Tanwandee T, Sukeepaisarnjaroen W, Chan HL, Pessôa MG, Fassio E, Ono SK, Bessone F, Daruich J, Zeuzem S, Cheinquer H, Pathan R, Dong Y, Trylesinski A. Piratvisuth T, et al. Among authors: bessone f. PLoS One. 2013;8(2):e54279. doi: 10.1371/journal.pone.0054279. Epub 2013 Feb 4. PLoS One. 2013. PMID: 23390496 Free PMC article. Clinical Trial.
Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial.
Sulkowski MS, Asselah T, Lalezari J, Ferenci P, Fainboim H, Leggett B, Bessone F, Mauss S, Heo J, Datsenko Y, Stern JO, Kukolj G, Scherer J, Nehmiz G, Steinmann GG, Böcher WO. Sulkowski MS, et al. Among authors: bessone f. Hepatology. 2013 Jun;57(6):2143-54. doi: 10.1002/hep.26276. Hepatology. 2013. PMID: 23359516 Clinical Trial.
115 results